Cheng-Chieh Fang

Title: Cheng-Chieh Fang: Innovator in Hepatitis B Research

Introduction

Cheng-Chieh Fang is a notable inventor based in Pingtung, Taiwan. He has made significant contributions to the field of medical research, particularly in understanding hepatitis B virus-associated diseases. His innovative work has led to the development of a unique animal disease model that aids in the study of hepatitis B.

Latest Patents

Cheng-Chieh Fang holds a patent for a non-human animal disease model for hepatitis B virus-associated liver disease. This model is transduced with a hepatitis B virus genome in the liver cells and exhibits various symptoms, including the presence of hepatitis B viral particles and DNA in the serum. The model also shows expression of HBV core and envelope proteins specifically in the liver, while other organs remain unaffected. Notably, this model can develop hepatocellular carcinoma, characterized by elevated alanine aminotransferase levels and liver pathological symptoms such as tumor nodules and fibrosis.

Career Highlights

Cheng-Chieh Fang is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work has been instrumental in advancing the understanding of hepatitis B and its associated complications. His research has implications for developing therapeutic strategies and improving patient outcomes.

Collaborations

Cheng-Chieh Fang has collaborated with esteemed colleagues, including Mi-Hua Tao and Ya-Hui Huang. These partnerships have enriched his research and contributed to the advancement of knowledge in the field of hepatitis B.

Conclusion

Cheng-Chieh Fang's innovative contributions to hepatitis B research through his patented animal disease model highlight his role as a key figure in medical research. His work continues to pave the way for future advancements in understanding and treating hepatitis B virus-associated diseases.